SINGULAIR PAED GRANULES 4 MG 28 S

Singulair is indicated in the treatment of asthma as add-on therapy in those 6 months to 5 year old patients with mild to moderate persistent asthma who are inadequately controlled on inhaled corticosteroids and in whom “ as-needed” short acting β -agonists provide inadequate clinical control of asthma.

Directions to use :

as directed by the physician

Side effects :

0 || trident > 0); } if (!isIE()) return; const hiddenInput = document.querySelector('#product-form-template--16020893139017__main input[name="id"]'); const noScriptInputWrapper = document.createElement('div'); const variantSwitcher = document.querySelector('variant-radios[data-section="template--16020893139017__main"]') || document.querySelector('variant-selects[data-section="template--16020893139017__main"]'); noScriptInputWrapper.innerHTML = document.querySelector('.product-form__noscript-wrapper-template--16020893139017__main').textContent; variantSwitcher.outerHTML = noScriptInputWrapper.outerHTML; document.querySelector('#Variants-template--16020893139017__main').addEventListener('change', function(event) { hiddenInput.value = event.currentTarget.value; }); });